论文部分内容阅读
非何杰金氏淋巴瘤(NHL)在病程中、血中出现原淋巴细胞者,称为非何杰金氏淋巴瘤型白血病(NHLL)。其发生率的高低与观察患者的时间长短和血液学检查的频率、病理类型、原发部位等有关。本文总结我院在1980-1984年间收治经病理、血液学检查证实的NHLL25例的临床表现及治疗效果,并复习有关文献,浅谈鉴别诊断等若干问题。临床资料一、一般资料自1980年1月至1984年2月,我院共收治经病理证实的恶性淋巴瘤共238例,全部作了骨髓检查。其中何杰金氏病45例,占18.9％;NHL193例,占81.1％。
Non-Hodgkin’s Lymphoma (NHL) During the course of the disease, there are premalignant lymphocytes in the blood known as non-Hodgkin’s lymphoma leukemia (NHLL). The incidence of the level of observation of patients with the length of time and the frequency of hematological examination, pathological type, the primary site and so on. This article summarizes the clinical manifestations and treatment effects of 25 cases of NHLL confirmed by pathology and hematology examination in our hospital from 1980 to 1984, and reviews the relevant literature, on the differential diagnosis of a number of issues. Clinical data First, the general information from January 1980 to February 1984, our hospital received a total of 238 cases of pathologically confirmed malignant lymphoma, all made a bone marrow examination. Hodgkin’s disease which 45 cases, accounting for 18.9%; NHL 193 cases, accounting for 81.1%.